EnLyteRX Announces JAYMAC Pharmaceuticals CEO Interview with CEO/CFO Magazine

Share Article

The August Edition of CEO/CFO Magazine Highlights an Interview with Harold Robinson, CEO of JayMac Pharmaceuticals, Makers of EnLyte and EnBrace HR enhanced folate therapies by prescription only.

The August edition of CEO/CFO Magazine features an interview with JayMac Pharmaceuticals CEO, Harold "Towny" Robinson. JayMac Pharmaceuticals has gained much attention due to its cutting-edge RX folate therapies, EnLyte and EnBrace HR. CEO/CFO Magazine is widely known as the most powerful name in corporate news and information. The full interview can be found here:


“People should pay attention to JayMac Pharmaceuticals primarily because our products have caught up to the science of the need for personalizing medication. EnLyte and EnBrace HR provide targeted folate needs for specific patient types, and if you can treat those patients’ folate deficiencies safely and effectively then you are way ahead of the game. Getting to the root cause of disease issues is very exciting.” -Towny Robinson, CEO, JayMac Pharmaceuticals

For questions, licensed prescriber samples or copay coupons, contact us now: 985-788-7755.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Angela Hall

Diane Pratt
since: 05/2013
Follow >
Like >
Visit website